Interestingly, we found that blocking CCL18, but not IL-6 and IL-8, significantly inhibited the upregulation of CD10 and GPR77 in NBFs exposed to chemoresistant tumor CM (Fig. 1F and Supplementary Fig. 1G, H). Here, CXCL8 is linked to neoplasm.